Sodium –glucose cotransporter 2 inhibitors and risk of nephrolithiasis

Conclusions/interpretationInitiation of treatment with SGLT2Is was associated with a clinically significant reduced risk of incident and recurrent nephrolithiasis.Graphical abstract
Source: Diabetologia - Category: Endocrinology Source Type: research